Immunophenotypic pattern of myeloid populations by flow cytometry analysis.

We present our experience with immunophenotypic characteristics of benign and malignant myeloid populations, with emphasis on differential diagnosis especially between eosinophils, dysplastic granulocytes, neoplastic promyelocytes, and monocytes. Eosinophils are characterized by bright CD45, high side scatter (SSC), very low forward scatter (FSC), positive CD11b, CD11c, CD13, CD15, and CD33. They are negative for CD10, CD14, CD16, CD56, CD64, and HLA-DR. Mature monocytes are positive for CD11b, CD11c, CD13, CD14, CD33, and CD64, and may express CD2 and CD4. Blasts in acute myeloid leukemias (AML) with minimal differentiation have low SSC and moderate CD45 expression and are positive for CD34, CD117, CD13, HLA-DR, and CD33 and may be positive for TdT, CD4, and CD11c. In acute promyelocytic leukemia (APL), four FC patterns can be recognized. The majority of cases represented classical (hypergranular) APL and were characterized by high SSC, positive CD117, usually negative CD34, heterogeneous CD13, and bright CD33 (pattern 1). The second most common type, corresponding to hypogranular (microgranular) variant of APL, differed from classical APL by low SSC and frequent coexpression of CD2 and CD34 (pattern 2). Rare cases of APL (pattern3) showed mixture of neoplastic cells (SSC(low)/CD2(+)/CD13(+)/CD33(+)/CD34(+)/CD117(+)) and prominent population of benign granulocytes/maturing myeloid precursors (SSC(high)/CD10(+/-)/CD16(+/()/CD117(()). One case showed two APL populations, one with hypogranular and one with hypergranular characteristics (pattern 4). Detailed phenotypic characteristics of neoplastic monocytes and dysplastic granulocytes with their differential diagnosis are also presented.

[1]  E. Weir,et al.  A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection , 1999, Leukemia.

[2]  A. Órfão,et al.  The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors , 2008, Leukemia.

[3]  R. Gressin,et al.  Identification of a leukemic counterpart of the plasmacytoid dendritic cells. , 2001, Blood.

[4]  A. Órfão,et al.  Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. , 1999, Clinical chemistry.

[5]  K. Foon,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. , 1997, Cytometry.

[6]  B. Wood,et al.  Multicolor immunophenotyping: human immune system hematopoiesis. , 2004, Methods in cell biology.

[7]  S. Lade,et al.  Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases. , 2006, Haematologica.

[8]  F. Craig,et al.  Flow cytometric immunophenotyping for hematologic neoplasms. , 2008, Blood.

[9]  B. Wood,et al.  Using 4-color flow cytometry to identify abnormal myeloid populations. , 2003, Archives of pathology & laboratory medicine.

[10]  Bruce Greig,et al.  2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia , 2007, Cytometry. Part B, Clinical cytometry.

[11]  David Gillis,et al.  The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. , 2009, American journal of clinical pathology.

[12]  Y. Li,et al.  Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. , 2005, American journal of clinical pathology.

[13]  M. Callanan,et al.  CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. , 2002, Blood.

[14]  P. Gogolák,et al.  Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells , 2005, European journal of haematology.

[15]  Giorgina Specchia,et al.  The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. , 2006, Haematologica.

[16]  M. Wasik,et al.  Complete remission in advanced blastic NK‐cell lymphoma/leukemia in elderly patients using the hyper‐CVAD regimen , 2003, American journal of hematology.

[17]  M. Mori,et al.  Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. , 2002, Blood.

[18]  B. Drénou,et al.  Clinical and biologic features of CD4(+)CD56(+) malignancies. , 2002, Blood.

[19]  P. Vyas,et al.  Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. , 2005, Blood.

[20]  E. Lianidou,et al.  Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes , 2009, Leukemia & lymphoma.

[21]  K. Foon,et al.  Flow cytometry: recent advances in diagnosis and monitoring of leukemia. , 1997, Cancer investigation.

[22]  V. V. D. van der Velden,et al.  Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. , 2008, Blood.

[23]  Melissa D'Archangelo.  Flow cytometry: New guidelines to support its clinical application , 2007, Cytometry. Part B, Clinical cytometry.

[24]  H. Kantarjian,et al.  Differences in CD33 intensity between various myeloid neoplasms. , 2002, American journal of clinical pathology.

[25]  R C Braylan,et al.  Analysis of Lymphomas by Flow Cytometry Current and Emerging Strategies , 1993, Annals of the New York Academy of Sciences.

[26]  D. Subirá,et al.  Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome. , 2006, Leukemia research.

[27]  W. Gorczyca.  Differential diagnosis of T-cell lymphoproliferative disorders by flow cytometry multicolor immunophenotyping. correlation with morphology. , 2004, Methods in cell biology.

[28]  H. Deeg,et al.  Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. , 2003, Blood.

[29]  C. Corrado,et al.  Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia , 2006, Cytometry. Part B, Clinical cytometry.

[30]  Olga Pozdnyakova,et al.  Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. , 2008, Leukemia research.

[31]  B. Wood,et al.  A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication , 2004, Leukemia.

[32]  K. Young,et al.  Myeloblast Phenotypic Changes in Myelodysplasia , 2006 .

[33]  T. Petrella,et al.  `Agranular CD4+ CD56+ Hematodermic Neoplasm' (Blastic NK-Cell Lymphoma) Originates From a Population of CD56+ Precursor Cells Related to Plasmacytoid Monocytes , 2002, The American journal of surgical pathology.

[34]  A. Órfão,et al.  Immunophenotypic analysis of myelodysplastic syndromes. , 2003, Haematologica.

[35]  R. Gascoyne,et al.  U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. , 1997, Cytometry.

[36]  B. Wood,et al.  2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Recommendations for training and education to perform clinical flow cytometry , 2007, Cytometry. Part B, Clinical cytometry.

[37]  J J Shuster,et al.  Minimal residual disease detection in childhood precursor–B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study , 2003, Leukemia.

[38]  D C Arthur,et al.  Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. , 2001, Blood.

[39]  H. Deeg,et al.  Flow Cytometry for Diagnosis and Assessment of Prognosis in Patients with Myelodysplastic Syndromes , 2004, Hematology.

[40]  M. Béné,et al.  CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. , 2003, Haematologica.

[41]  R. Braylan,et al.  Flow cytometric analysis of lymphomas. , 1989, Archives of pathology & laboratory medicine.

[42]  M. Roederer,et al.  A practical approach to multicolor flow cytometry for immunophenotyping. , 2000, Journal of immunological methods.

[43]  K. Ogata.  Diagnostic flow cytometry for low‐grade myelodysplastic syndromes , 2008, Hematological oncology.

[44]  Jennings Cd,et al.  Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy , 1997 .

[45]  V. Deneys,et al.  Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts , 2004, European journal of immunology.

[46]  A. Órfão,et al.  Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalities. , 2004, The hematology journal : the official journal of the European Haematology Association.

[47]  M. Borowitz,et al.  Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. , 1993, American journal of clinical pathology.

[48]  B. Drénou,et al.  Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. , 2004, Blood.

[49]  W. Gorczyca.  Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML). , 2004, Methods in cell biology.

[50]  M. Hino,et al.  Blastic NK-cell lymphoma/leukemia with T-cell receptor γ rearrangement , 2001, Annals of Hematology.

[51]  R. Braylan,et al.  Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[52]  R. Braylan,et al.  Flow cytometric analysis of lymphomas and lymphoproliferative disorders. , 2001, Seminars in hematology.

[53]  M. Borowitz,et al.  Flow cytometry in the diagnosis of acute leukemia. , 2001, Seminars in hematology.

[54]  N. Shinton.  WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[55]  M. Cazzola,et al.  Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome , 2005, Leukemia.

[56]  F. Garnache-Ottou,et al.  Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? , 2007, British journal of haematology.

[57]  R. Cleveland,et al.  Decreased CD10-positive mature granulocytes in bone marrow from patients with myelodysplastic syndrome. , 2000, Archives of pathology & laboratory medicine.

[58]  B. Brando,et al.  Prognostic value of circulating CD34+ cells in myelodysplastic syndromes. , 2008, Leukemia research.

[59]  D. Campana,et al.  Minimal residual disease monitoring by flow cytometry. , 2003, Best practice & research. Clinical haematology.

[60]  Nicola Pimpinelli,et al.  WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.

[61]  C. D. Wu,et al.  An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. , 2002, Cytometry.

[62]  C. D. Wu,et al.  Differential diagnosis of malignant lymphomas and related disorders by specific pattern of expression of immunophenotypic markers revealed by multiparameter flow cytometry (Review). , 2000, International journal of oncology.